跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Irbegen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Irbegen
Approved
STANDARD
Irbegen
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9ca4b53bd47eb064
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
9ca4b53bd47eb064
Drug Approval Philippines Name
Irbegen
Product Name
Irbegen
Registration Number
DR-XY39986
Brand Name
Irbegen
Generic Name
Irbesartan
Dosage Form
Film-Coated Tablet
Dosage Strength
300 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Innogen Pharmaceuticals, Inc.
Distributor
TGP Pharma Inc.
Issuance Date
27 May 2024
Expiry Date
02 September 2029
Pharmacologic Category
Angiotensin II Receptor Blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9ca4b53bd47eb064
Type
Standard
Back to Philippines FDA Approvals